Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
181.7 GBX | +0.06% | +0.28% | +12.34% |
May. 10 | StanChart exec sells shares; new Alphawave CFO buys | AN |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 4.81B 6.12B | Sales 2025 * | 4.99B 6.35B | Capitalization | 1.95B 2.48B |
---|---|---|---|---|---|
Net income 2024 * | 152M 193M | Net income 2025 * | 163M 207M | EV / Sales 2024 * | 0.53 x |
Net Debt 2024 * | 618M 786M | Net Debt 2025 * | 505M 643M | EV / Sales 2025 * | 0.49 x |
P/E ratio 2024 * |
13.4
x | P/E ratio 2025 * |
11.6
x | Employees | 50,000 |
Yield 2024 * |
2.19% | Yield 2025 * |
2.54% | Free-Float | 97.99% |
Latest transcript on Serco Group plc
1 day | +0.06% | ||
1 week | +0.05% | ||
Current month | -0.82% | ||
1 month | -0.17% | ||
3 months | +1.11% | ||
6 months | +16.03% | ||
Current year | +12.09% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Irwin
CEO | Chief Executive Officer | 59 | 13-03-31 |
Nigel Crossley
DFI | Director of Finance/CFO | 61 | 13-12-31 |
Paul Checketts
IRC | Investor Relations Contact | - | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Irwin
CEO | Chief Executive Officer | 59 | 13-03-31 |
Lynne Peacock
BRD | Director/Board Member | 70 | 17-06-30 |
John Rishton
CHM | Chairman | 66 | 16-09-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 182.1 | +0.28% | 65 966 |
24-05-22 | 181.6 | +0.33% | 3,070,369 |
24-05-21 | 181 | -1.52% | 1,417,779 |
24-05-20 | 183.8 | +0.66% | 1,165,688 |
24-05-17 | 182.6 | +0.55% | 2,205,935 |
Delayed Quote London S.E., May 23, 2024 at 04:40 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.09% | 2.48B | |
+16.45% | 71.21B | |
+6.22% | 17.26B | |
+13.63% | 13.96B | |
+21.56% | 13.54B | |
+16.25% | 10.13B | |
-18.78% | 7.05B | |
-1.24% | 6.17B | |
+2.30% | 5.22B | |
+1.00% | 5.06B |
- Stock Market
- Equities
- SRP Stock